Navigation Links
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Date:7/26/2013

BOSTON, July 26, 2013 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the appointment of Gino Santini to its Board of Directors. Mr. Santini is a former top executive with Eli Lilly and Company, and is globally respected in the industry after nearly three decades of global pharmaceutical experience. Mr. Santini now will help guide Intarcia through the final stages of development, partnering, and early commercialization of its lead therapeutic candidate, ITCA 650 (a breakthrough once- or twice-yearly GLP-1 for type 2 diabetes that is currently in Phase 3 clinical trials). Mr. Santini will also have significant input on the continuing efforts to build out the Company's product pipeline.

"As we look to continue to strengthen our Board, Gino stood out as an exceptional candidate and proven leader in the industry whose qualifications are well suited to help us meet all our opportunities to advance our Company," said Kurt Graves, Chairman, President and CEO of Intarcia. "We are delighted to welcome Gino to the Intarcia Board of Directors, and we look forward to gaining the benefit of his extensive global operating experience, all of his business development acumen, and his in-depth knowledge and insights in the diabetes marketplace."

Gino Santini began his distinguished career at Lilly as a Financial Planning Associate in Italy in 1983 and subsequently served in roles of increasing responsibility, including: Pharmaceutical Director in Belgium, General Manager in Mexico City, Area Director of Latin America, President of Lilly's women's health business, and President of U.S. Operations. In his final role as Senior Vice President of Corporate Strategy and Business Development and a member o
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Amgen (NASDAQ: AMGN ... a $0.79 per share dividend for the third quarter ... 8, 2015, to all stockholders of record as of ... About Amgen Amgen is committed to unlocking ... illnesses by discovering, developing, manufacturing and delivering innovative human ...
(Date:7/28/2015)... Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ) ... financial results after the market closes on Tuesday, August ... will be held on Tuesday, August 4, 2015, at ... To participate in the call, please dial 877-303-1298 ... rebroadcast of the teleconference will be available for one ...
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has announced the ... Global Forecasts to 2019" report to their offering. ... estimated to grow expected to reach $9.37 billion by ... 2019. Factors such as growing ... increasing privatization in the healthcare sector, and rising adoption ...
Breaking Medicine Technology:Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Cumberland Pharmaceuticals To Announce Second Quarter 2015 Financial Results 2Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2
... , NEWNAN, Ga., Dec. 1 CeloNova BioSciences, Inc., ... of specialty implants, today announced that Barry Katzen, MD, FACR, ... Vascular Institute in Miami, Florida, will discuss the CATANIA(TM) Stent ... Conference to be held at the Hotel David InterContinental in ...
... , PLEASANTON, Calif., Dec. ... Commercial Affairs at Microchip Biotechnologies, Inc. has been taken ... with more than 30 years of experience creating and ... Microchip Biotechnologies, marketing, business development, sales and customer service ...
Cached Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2
(Date:7/29/2015)... , ... July 29, 2015 , ... Several years ago, ... of children with autism, Little City took a proactive stance and began planning the ... Coleman Foundation grant provides valuable support to building the third home. , “We are ...
(Date:7/29/2015)... Louis, MO (PRWEB) , ... July 29, 2015 , ... ... website, the Talcum Powder Cancer Lawsuit Center. The website now features a page dedicated ... and news pieces from other sources. The Talcum Powder Lawsuit News page ...
(Date:7/29/2015)... ... 2015 , ... Toronto native Douglas James Cottrell, Ph.D., has ... been making predictions about the economy, politics, social issues, as well as the ... warns that extreme weather conditions and increased earthquake / volcanic activity will increase ...
(Date:7/29/2015)... ... July 29, 2015 , ... " mybody ” was featured on ... medium and large businesses making an impact in their industry. Andrew Tropeano, the host ... these advanced probiotic skincare products are designed to strengthen the skin’s defense system from ...
(Date:7/29/2015)... ... July 29, 2015 , ... National non-profit World ... life insurance, annuities, employee benefits and asset management, has joined as presenting sponsor ... taking place in Charlotte, North Carolina on October 2-4, 2015. , Hosted at ...
Breaking Medicine News(10 mins):Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3
... and other cancers, researchers say , , SUNDAY, May ... patients with follicular non-Hodgkin lymphoma who received a vaccine ... 44 months before relapsing, compared to only 30.6 months ... vaccine trial was one of several studies from the ...
... IL (May 31, 2009) - New research quantifies the ... gastrointestinal (GI) health. Both studies being presented this week ... ) offer concrete evidence that the environment and alcohol ... into new directions for future research. DDW is the ...
... efficacy against malignancies that don,t respond to other drugs ... combination of the drugs temsirolimus (Torisel) and Bryostatin appears ... according to early data from 25 patients in a ... known as mTOR signaling promotes tumor cell proliferation and ...
... 2009 The American Society for Gastrointestinal Endoscopy (ASGE) ... the fifth annual ASGE Crystal Awards on Sunday, May 31. ... will begin at 6:30 p.m. at Navy Pier in Chicago. ... the ASGE Crystal Awards symbolize the finest in leadership, research ...
... hot flashes, studies suggest , , SUNDAY, May 31 (HealthDay ... survivors use to dampen the hot flashes caused by ... disease,s return, new research warns. , The finding was ... Oncology,s annual meeting, in Orlando, Fla. , But to ...
... part of the Elekta Group, today awarded the 2009 ... award to Deanna Derdelinghen, Certified Tumor Registrar (CTR(R)) ... Software,s Registrar of the Year program honors ... the success of their registry and extend their contributions ...
Cached Medicine News:Health News:Immune-Based Lymphoma Treatment Shows Promise 2Health News:Immune-Based Lymphoma Treatment Shows Promise 3Health News:Immune-Based Lymphoma Treatment Shows Promise 4Health News:Immune-Based Lymphoma Treatment Shows Promise 5Health News:To what extent can environmental pollutants and alcohol affect GI health? 2Health News:To what extent can environmental pollutants and alcohol affect GI health? 3Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 2Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 3Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 4Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 5Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 6Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 7Health News:Some Antidepressants May Thwart Tamoxifen's Effect on Breast Cancer 2Health News:Some Antidepressants May Thwart Tamoxifen's Effect on Breast Cancer 3Health News:Impac Software Selects 2009 Cancer Registrar of the Year 2Health News:Impac Software Selects 2009 Cancer Registrar of the Year 3
... Volks state-of-the-art 20D diagnostic/laser lens is ... aberrations and coma delivering the ... diopter lens on the market. Its ... linear image magnification and perfect image ...
... Macula Plus® 5.5 is ... of the optic nerve ... it with your binocular ... choroidal neovascular membranes, macular ...
... Automated Urine Microscopy Analyzer (iQ200) uses ... software to classify urine particles into ... The iQ200 eliminates most technologist time ... images by automating specimen preparation, image ...
... based on the C6 peptide antigen, a 26 ... This peptide has been shown to represent ... of the antigenic reactivity of the whole protein. ... peptide is a sensitive and specific marker for ...
Medicine Products: